Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anika Therapeutics (ANIK) Current Deferred Revenue: 2010-2018

Historic Current Deferred Revenue for Anika Therapeutics (ANIK) over the last 5 years, with Sep 2018 value amounting to $52,000.

  • Anika Therapeutics' Current Deferred Revenue was N/A to $52,000 in Q3 2018 from the same period last year, while for Sep 2018 it was $52,000, marking a year-over-year change of. This contributed to the annual value of $24,510 for FY2014, which is 98.90% down from last year.
  • Latest data reveals that Anika Therapeutics reported Current Deferred Revenue of $52,000 as of Q3 2018, which was down 29.73% from $74,000 recorded in Q2 2018.
  • In the past 5 years, Anika Therapeutics' Current Deferred Revenue registered a high of $139,535 during Q1 2015, and its lowest value of $12,885 during Q3 2014.
  • Over the past 1 years, Anika Therapeutics' median Current Deferred Revenue value was $63,000 (recorded in 2018), while the average stood at $63,000.
  • Its Current Deferred Revenue has fluctuated over the past 5 years, first slumped by 98.99% in 2014, then skyrocketed by 200.64% in 2015.
  • Over the past 3 years, Anika Therapeutics' Current Deferred Revenue (Quarterly) stood at $24,510 in 2014, then soared by 163.47% to $33,948 in 2015, then reached $52,000 in 2018.
  • Its Current Deferred Revenue was $52,000 in Q3 2018, compared to $74,000 in Q2 2018 and $33,948 in Q3 2015.